Literature DB >> 21636562

Inflammatory cells and apoptosis in respiratory and limb muscles of patients with COPD.

Esther Barreiro1, Dolores Ferrer, Francisco Sanchez, Joan Minguella, Judith Marin-Corral, Juana Martinez-Llorens, Josep Lloreta, Joaquim Gea.   

Abstract

Discrepancies exist regarding the involvement of cellular inflammation and apoptosis in the muscle dysfunction of chronic obstructive pulmonary disease (COPD) patients with preserved body composition. We explored whether levels of inflammatory cells and apoptosis were increased in both respiratory and limb muscles of COPD patients without nutritional abnormalities. In the vastus lateralis, external intercostals, and diaphragms of severe and moderate COPD patients with normal body composition, and in healthy subjects, intramuscular leukocytes and macrophage levels were determined (immunohistochemistry). Muscle structure was also evaluated. In the diaphragm and vastus lateralis of severe and moderate COPD patients and controls, apoptotic nuclei were explored using the terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay, electron microscopy, and caspase-3 expression. In COPD patients compared with controls, diaphragm and intercostal levels of inflammatory cells were extremely low and not significantly different. However, in the vastus lateralis of the severe patients, inflammatory cell counts, although also very low, were significantly greater. In those patients, TUNEL-positive nuclei levels were also significantly greater in diaphragms and vastus lateralis. A significant inverse relationship was found between quadriceps TUNEL-positive nuclei levels and muscle force. Ultrastructural apoptotic nuclei revealed no differences in respiratory or limb muscles between COPD patients and controls. Muscle caspase-3 expression did not differ between patients and controls. In severe COPD patients with preserved body composition, while increased apoptotic nuclei seems to be a contributor to their muscle dysfunction, cellular inflammation does not. The increased numbers of TUNEL-positive nuclei in their muscles suggest that they may also be exposed to a continuous repair/remodeling process.

Entities:  

Mesh:

Year:  2011        PMID: 21636562     DOI: 10.1152/japplphysiol.01017.2010

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  23 in total

Review 1.  Molecular and biological pathways of skeletal muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  Esther Barreiro; Joaquim Gea
Journal:  Chron Respir Dis       Date:  2016-04-06       Impact factor: 2.444

Review 2.  Muscle atrophy in chronic obstructive pulmonary disease: molecular basis and potential therapeutic targets.

Authors:  Esther Barreiro; Ariel Jaitovich
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

Review 3.  Muscle dysfunction in chronic obstructive pulmonary disease: update on causes and biological findings.

Authors:  Joaquim Gea; Sergi Pascual; Carme Casadevall; Mauricio Orozco-Levi; Esther Barreiro
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

Review 4.  An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease.

Authors:  François Maltais; Marc Decramer; Richard Casaburi; Esther Barreiro; Yan Burelle; Richard Debigaré; P N Richard Dekhuijzen; Frits Franssen; Ghislaine Gayan-Ramirez; Joaquim Gea; Harry R Gosker; Rik Gosselink; Maurice Hayot; Sabah N A Hussain; Wim Janssens; Micheal I Polkey; Josep Roca; Didier Saey; Annemie M W J Schols; Martijn A Spruit; Michael Steiner; Tanja Taivassalo; Thierry Troosters; Ioannis Vogiatzis; Peter D Wagner
Journal:  Am J Respir Crit Care Med       Date:  2014-05-01       Impact factor: 21.405

Review 5.  Deterioration of Limb Muscle Function during Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Authors:  Raolat M Abdulai; Tina Jellesmark Jensen; Naimish R Patel; Michael I Polkey; Paul Jansson; Bartolomé R Celli; Stephen I Rennard
Journal:  Am J Respir Crit Care Med       Date:  2018-02-15       Impact factor: 21.405

Review 6.  Epigenetic regulation of muscle phenotype and adaptation: a potential role in COPD muscle dysfunction.

Authors:  Esther Barreiro; Jacob I Sznajder
Journal:  J Appl Physiol (1985)       Date:  2013-01-10

7.  Genome-wide mRNA expression profiling in vastus lateralis of COPD patients with low and normal fat free mass index and healthy controls.

Authors:  Roberto A Rabinovich; Ellen Drost; Jonathan R Manning; Donald R Dunbar; MaCarmen Díaz-Ramos; Ramzi Lakhdar; Ricardo Bastos; William MacNee
Journal:  Respir Res       Date:  2015-01-08

Review 8.  Structural alterations of skeletal muscle in copd.

Authors:  Sunita Mathur; Dina Brooks; Celso R F Carvalho
Journal:  Front Physiol       Date:  2014-03-19       Impact factor: 4.566

9.  Do epigenetic events take place in the vastus lateralis of patients with mild chronic obstructive pulmonary disease?

Authors:  Ester Puig-Vilanova; Pilar Ausin; Juana Martinez-Llorens; Joaquim Gea; Esther Barreiro
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

10.  Systemic and pulmonary inflammation is independent of skeletal muscle changes in patients with chronic obstructive pulmonary disease.

Authors:  Bethan L Barker; Susan McKenna; Vijay Mistry; Mitesh Pancholi; Hemu Patel; Koirobi Haldar; Michael R Barer; Ian D Pavord; Michael C Steiner; Christopher E Brightling; Mona Bafadhel
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.